REDEFINING FUTILITY IN THE MACHINE PERFUSION ERA: INSIGHTS BASED ON THE UK-DCD RISK SCORE IN 362 DCD LIVER TRANSPLANTATIONS

Efrayim Küçükerbil:Surgery,Erasmus MC Transplant Institute,Rotterdam,Netherlands|Femke de Goeij:Surgery,Erasmus MC Transplant Institute,Rotterdam,Netherlands|Puck Groen:Surgery,Erasmus MC Transplant Institute,Rotterdam,Netherlands|Lina Gruncell:Surgery,Erasmus MC Transplant Institute,Rotterdam,Netherlands|Roberto Broere:Surgery,Erasmus MC Transplant Institute,Rotterdam,Netherlands|Sarwa Darwish Murad:Gastroenterology and Hepatology,Erasmus MC Transplant Institute,Rotterdam,Netherlands|Caroline den Hoed:Gastroenterology and Hepatology,Erasmus MC Transplant Institute,Rotterdam,Netherlands|Robert Porte:Surgery,Erasmus MC Transplant Institute,Rotterdam,Netherlands|Wojciech Polak:Surgery,Erasmus MC Transplant Institute,Rotterdam,Netherlands|Jeroen de Jonge:Surgery,Erasmus MC Transplant Institute,Rotterdam,Netherlands

REDUCED TRANSPLANT ACCESS BUT COMPARABLE AGE-ADJUSTED LONG-TERM OUTCOMES IN MASLD-ASSOCIATED HCC: A UK REGISTRY ANALYSIS

Abdullah Khawaja:Institute of Liver Studies,King’s College Hospital NHS Foundation Trust,London,United Kingdom|David Wallace:Institute of Liver Studies,King’s College Hospital NHS Foundation Trust,London,United Kingdom|Rhiannon Taylor:Institute of Liver Studies,King’s College Hospital NHS Foundation Trust,London,United Kingdom|Maria Guerra Veloz:Institute of Liver Studies,King’s College Hospital NHS Foundation Trust,London,United Kingdom|Parthi Srinivasan:Institute of Liver Studies,King’s College Hospital NHS Foundation Trust,London,United Kingdom|Krishna Menon:Institute of Liver Studies,King’s College Hospital NHS Foundation Trust,London,United Kingdom|Abid Suddle:Institute of Liver Studies,King’s College Hospital NHS Foundation Trust,London,United Kingdom|Varuna Aluvihare:Institute of Liver Studies,King’s College Hospital NHS Foundation Trust,London,United Kingdom|Abdul Rahman Hakeem:Institute of Liver Studies,King’s College Hospital NHS Foundation Trust,London,United Kingdom

PRE-DONATION HYPERNATREMIA AND ELEVATED LACTATE ARE LINKED TO REDUCED SURVIVAL OUTCOMES AFTER LIVER TRANSPLANTATION: A UK REGISTRY ANALYSIS

Ahmed Sherif:Edinburgh Transplant Centre,Royal Infirmary of Edinburgh,Edinburgh,United Kingdom;Clinical Surgery,University of Edinburgh,Edinburgh,United Kingdom|Rhiannon Wallis:3NHS Blood & Transplant, Statistics and Clinical Research,Bristol,United Kingdom|Rhiannon Taylor:3NHS Blood & Transplant, Statistics and Clinical Research,Bristol,United Kingdom|Anya Adair:Edinburgh Transplant Centre,Royal Infirmary of Edinburgh,Edinburgh,United Kingdom;Clinical Surgery,University of Edinburgh,Edinburgh,United Kingdom

CLINICAL APPLICATION OF ANGIOTENSIN II INFUSION IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS

Megan Crawford:Baylor College of Medicine,Houston,United States|Garrett Wortham:Baylor College of Medicine,Houston,United States|Divya Sabapathy:Pediatrics,Baylor College of Medicine,Houston,United States|Dana Cerminara:Pharmacy,Texas Childrens Hospital,Houston,United States|John A Goss:Abdominal Transplant,Baylor College of Medicine,Houston,United States|Manpreet Virk :Pediatrics,Baylor College of Medicine,Houston,United States|Moreshwar Desai:Pediatrics,Baylor College of Medicine,Houston,United States|Fong Lam:Pediatrics,Baylor College of Medicine,Houston,United States|Anna Banc-Husu:Pediatrics,Baylor College of Medicine,Houston,United States|Naseem Ravanbakhsh:Pediatrics,Baylor College of Medicine,Houston,United States|Nhu Thao Galvan:Abdominal Transplant,Baylor College of Medicine,Houston,United States

ISCHEMIA-FREE LIVER IMPLANTATION-ENHANCED DHOPE-COR-NMP PROTOCOL FACILITATES SAFE TRANSPLANTATION OF SEVERELY STEATOTIC LIVER GRAFTS

Mikhail Boldyrev:Surgical department №2 (Liver transplantation),V.I. Shumakov Transplantation & Artificial Organs National Medical Research Center,Moscow,Russian Federation|Artem Monakhov:Surgical department №2 (Liver transplantation),V.I. Shumakov Transplantation & Artificial Organs National Medical Research Center,Moscow,Russian Federation;Department of transplantation and artificial organs,I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation,Moscow,Russian Federation|Stepan Zubenko:Surgical department №2 (Liver transplantation),V.I. Shumakov Transplantation & Artificial Organs National Medical Research Center,Moscow,Russian Federation|Nikita Grudinin:Laboratory of biotechnical systems,V.I. Shumakov Transplantation & Artificial Organs National Medical Research Center,Moscow,Russian Federation|Vladimir Bogdanov:Laboratory of biotechnical systems,V.I. Shumakov Transplantation & Artificial Organs National Medical Research Center,Moscow,Russian Federation|Denis Bondarenko:Department of extracorporal circulation,V.I. Shumakov Transplantation & Artificial Organs National Medical Research Center,Moscow,Russian Federation|Vyacheslav Salimov:Surgical department №2 (Liver transplantation),V.I. Shumakov Transplantation & Artificial Organs National Medical Research Center,Moscow,Russian Federation|Nidzhat Usuf:Surgical department №2 (Liver transplantation),V.I. Shumakov Transplantation & Artificial Organs National Medical Research Center,Moscow,Russian Federation|Olga Tsirulnikova:Transplant hepatology department,V.I. Shumakov Transplantation & Artificial Organs National Medical Research Center,Moscow,Russian Federation;Department of transplantation and artificial organs,I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation,Moscow,Russian Federation|Sergey Gautier:Surgical department №2 (Liver transplantation),V.I. Shumakov Transplantation & Artificial Organs National Medical Research Center,Moscow,Russian Federation;Department of transplantation and artificial organs,I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation,Moscow,Russian Federation

HYPOXIA-FREE LIVER IMPLANTATION USING THE DHOPE-SWIFT PROTOCOL: NOTES FROM THE PILOT STUDY

Mikhail Boldyrev:Surgical department №2 (Liver transplantation),V.I. Shumakov Transplantation & Artificial Organs National Medical Research Center,Moscow,Russian Federation|Artem Monakhov:Surgical department №2 (Liver transplantation),V.I. Shumakov Transplantation & Artificial Organs National Medical Research Center,Moscow,Russian Federation;Department of transplantation and artificial organs,I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation,Moscow,Russian Federation|Stepan Zubenko:Surgical department №2 (Liver transplantation),V.I. Shumakov Transplantation & Artificial Organs National Medical Research Center,Moscow,Russian Federation|Nikita Grudinin:Laboratory of biotechnical systems,V.I. Shumakov Transplantation & Artificial Organs National Medical Research Center,Moscow,Russian Federation|Vladimir Bogdanov:Laboratory of biotechnical systems,V.I. Shumakov Transplantation & Artificial Organs National Medical Research Center,Moscow,Russian Federation|Denis Bondarenko:Department of extracorporal circulation,V.I. Shumakov Transplantation & Artificial Organs National Medical Research Center,Moscow,Russian Federation|Vyacheslav Salimov:Surgical department №2 (Liver transplantation),V.I. Shumakov Transplantation & Artificial Organs National Medical Research Center,Moscow,Russian Federation|Nidzhat Usuf:Surgical department №2 (Liver transplantation),V.I. Shumakov Transplantation & Artificial Organs National Medical Research Center,Moscow,Russian Federation|Olga Tsirulnikova:Transplant hepatology department,V.I. Shumakov Transplantation & Artificial Organs National Medical Research Center,Moscow,Russian Federation;Department of transplantation and artificial organs,I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation,Moscow,Russian Federation|Sergey Gautier:Surgical department №2 (Liver transplantation),V.I. Shumakov Transplantation & Artificial Organs National Medical Research Center,Moscow,Russian Federation;Department of transplantation and artificial organs,I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation,Moscow,Russian Federation

EPIDEMIOLOGY AND IMPACT OF CHRONIC KIDNEY DISEASE IN LIVER TRANSPLANT RECIPIENTS - A SWISS TRANSPLANT COHORT STUDY

Christian Tibor Josef Magyar:Department of Visceral Surgery and Medicine,Inselspital, Bern University Hospital, University of Bern,Bern,Switzerland|Caroline Wehmeier:Clinic for Transplantation Immunology and Nephrology,University Hospital Basel,Basel,Switzerland|Vanessa Banz:Department of Visceral Surgery and Medicine,Inselspital, Bern University Hospital, University of Bern,Bern,Switzerland|Guido Beldi:Department of Visceral Surgery and Medicine,Inselspital, Bern University Hospital, University of Bern,Bern,Switzerland|Michele Martinelli:Centre for Advanced Heart Failure, Department of Cardiology,Inselspital, Bern University Hospital,Bern,Switzerland|Fadi Haidar:Department of Medicine, Division of Nephrology,University Hospital of Geneva,Geneva,Switzerland|Giulia Magini:Division of Transplantation, Department of Surgery,Geneva University Hospitals,Geneva,Switzerland|Déla Golshayan:Transplantation center,Lausanne University Hospital and University of Lausanne,Lausanne,Switzerland|Matthieu Halfon:Service of nephrology, Department of Medicine,State Hospital Fribourg,Fribourg,Switzerland;Transplantation Center,Lausanne University Hospital,Lausanne,Switzerland|Julien Vionnet:Transplantation Center, Service of Immunology and Allergy, and Service of Gastroenterology and Hepatology,University Hospital of Lausanne,Lausanne,Switzerland|Christian Kuhn:Division of Nephrology and Transplantation Medicine,HOCH Cantonal Hospital St. Gallen,St. Gallen,Switzerland|Thomas Schachtner:Division of Nephrology,University Hospital Zurich,Zurich,Switzerland|Pierre-Yves Bochud:Infectious Diseases Service, Department of Medicine,Lausanne University Hospital (CHUV) and University of Lausanne (UNIL),Lausanne,Switzerland|Laura Walti:Department of Infectious Diseases,Inselspital, Bern University Hospital, University of Bern,Bern,Switzerland|Daniel Sidler:Department for Nephrology and Hypertension,Inselspital, Bern University Hospital, University of Bern,Bern,Switzerland

SALVAGING REFRACTORY ANTIBODY-MEDIATED REJECTION IN PEDIATRIC LIVER TRANSPLANT PATIENTS AT A HIGH-VOLUME TRANSPLANT CENTER: A CASE SERIES AND SYSTEMATIC REVIEW

Parastou S Khalessi Hosseini:Gastroenterology, Hepatology, and Nutrition,Childrens Hospital Los Angeles,Los Angeles,United States;University Of Southern California ,Los Angeles,United States|Arianna Barbetta:University Of Southern California ,Los Angeles,United States;Childrens Hospital Los Angeles,Los Angeles,United States|Nour Hassan:University of Vermont,Burlington,United States|Sarah Bangerth:University Of Southern California ,Los Angeles,United States|Ronald Martinez:University Of Southern California ,Los Angeles,United States;Childrens Hospital Los Angeles,Los Angeles,United States|Shengmei Zhou:University Of Southern California ,Los Angeles,United States;Childrens Hospital Los Angeles,Los Angeles,United States|Kambiz Etesami:University Of Southern California ,Los Angeles,United States;Childrens Hospital Los Angeles,Los Angeles,United States|Rohit Kohli:Childrens Hospital Los Angeles,Los Angeles,United States;University Of Southern California ,Los Angeles,United States|Juliet Emamaullee:University Of Southern California ,Los Angeles,United States;Childrens Hospital Los Angeles,Los Angeles,United States

ACCESSIBLE ECMO-BASED MACHINE PERFUSION ENABLES EARLY VIABILITY ASSESSMENT IN DCD PORCINE LIVERS

Julio Benitez:CRCHUM ,Montreal,Canada;HPB and Transplant,Hospital Dr. Sotero del Rio,Santiago ,Chile|Julien Côté:CRCHUM ,Montreal,Canada|Rolando Rebolledo:CRCHUM ,Montreal,Canada;HPB and Transplant,Hospital Dr. Sotero del Rio,Santiago ,Chile|Yara Haddad:CRCHUM ,Montreal,Canada|Marylène Plasse:CRCHUM ,Montreal,Canada|Ève Beaudry-Simoneau:CRCHUM ,Montreal,Canada;HPB and Transplant,CHUM,Montreal,Canada|Zhixia Rong:CRCHUM ,Montreal,Canada|Franck Vandenbroucke-Menu:CRCHUM ,Montreal,Canada;HPB and Transplant,CHUM,Montreal,Canada|Ahmed Menaouar:CRCHUM ,Montreal,Canada|Mélanie Borie:CRCHUM ,Montreal,Canada|Shant Der Sarkissian:CRCHUM ,Montreal,Canada|David Henault:CRCHUM ,Montreal,Canada;HPB and Transplant,CHUM,Montreal,Canada|Nicolas Noiseux:CRCHUM ,Montreal,Canada|Simon Turcotte:CRCHUM ,Montreal,Canada;HPB and Transplant,CHUM,Montreal,Canada

VANISHING BILE DUCT SYNDROME AFTER NIVOLUMAB THERAPY IN A LIVER TRANSPLANT RECIPIENT: A CASE REPORT AND LITERATURE REVIEW

Andy Yizhou Wu:Division of Hepatology and Liver Transplant,University of Pittsburgh Medical Center,Pittsburgh,United States|Stela Celaj:Division of Hepatology and Liver Transplant,University of Pittsburgh Medical Center,Pittsburgh,United States